We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

National Research Corp (NRC) USD0.001 A

Sell:$39.38 Buy:$39.50 Change: $0.28 (0.71%)
NASDAQ:0.51%
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Ex-dividend
Sell:$39.38
Buy:$39.50
Change: $0.28 (0.71%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Ex-dividend
Sell:$39.38
Buy:$39.50
Change: $0.28 (0.71%)
Market closed |  Prices as at close on 27 March 2024 | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The Company's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.

Contact details

Address:
1245 Q St
LINCOLN
68508
United States
Telephone:
+1 (402) 4752525
Website:
https://nrchealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NRC
ISIN:
US6373722023
Market cap:
$947.02 million
Shares in issue:
23.85 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Michael Hays
    President, Chief Executive Officer, Director
  • Kevin Karas
    Chief Financial Officer, Senior Vice President - Finance, Treasurer, Secretary
  • Jason Hahn
    Chief Revenue Officer
  • Helen Hrdy
    Chief Customer Officer
  • Christophe Louvion
    Chief Product Technology Officer
  • Andy Monnich
    Chief Corporate Development Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.